Skip to main content

Critical and Non-critical Areas in Pharmaceutical Manufacturing

Critical and Non-critical Areas in Pharmaceutical Manufacturing

Sterile areas in pharmaceuticals where the sterile product is exposed to air are considered as critical area and other adjacent area are known as non-critical areas.

Appropriate design, positioning and use of critical and non-critical areas in the pharmaceutical manufacturing process are among the key prerequisites for success in this industry. Critical areas include all areas in which any kind of sterile product (including both drugs and equipment) must be exposed to the sterile environment and where activities including sterilization, sterile filling and closing take place.

Aseptic preparation and support rooms are also critical areas. All other areas in the manufacturing process are considered the non-critical areas. A well-designed flow of the work process which avoids critical and non-critical areas mixing must ensure avoiding contamination of any kind.

Additionally, pharmaceutical industry laboratories require extremely high levels of air exchange. These and many other parameters, standards and procedures ensure that the s terile products remain sterile prior to, during and after the manufacturing process.

The first stage in this process requires a planning of the manufacturing facility. Regardless of the protective measures taken during the manufacturing process itself, an inadequate architectural design of the facility itself will lead to an increased risk of contamination. Guidelines for architects and engineers include strategic planning of vicinity, direct connectivity, crossing (including both materials and personnel crossing), vertical and horizontal communications between critical and non-critical zones.

This is especially applicable to complete separation of the clean areas from eating zones and restrooms in any GMP manufacturing facility. It is important to position the corridors along the supporting rooms instead of the clean rooms, as crossing between the critical area personnel and non- critical area personnel is minimized in this way.

Furthermore, the air shafts between these two types of areas must comply with the following rule: air shafts should be designed in a way that pushes the air from the clean zones to the less clean zones and never vice versa. If clean and unclean areas are adjacent to each other, the risk of contamination is avoided by providing the pressure difference between the zones.

Experts advise that the pressure difference should be at least 12 Pa. A larm system ensuring the pressure difference levels is highly advised as well.

20 air changes/hours is the current standard for supporting rooms. Temperature control systems, as well as humidity control systems, are inseparable parts of quality control in pharmaceutical industry.

Critical Areas Personnel Optimization

The number of staff operating in the clean areas should be minimized. More importantly, the staff mobility and terms of entering the critical areas must be specified and limited. Automation and robotics offer significant improvements regarding this issue.

The Role of Choice of Building Materials in Critical Areas

Building materials used in clean rooms must be chosen on basis of ease of cleaning. Wall to floor junctions and wall to ceiling junctions must be seamless. The ceilings should be sealed. Furthermore, ergonomic design of both the facility critical zones and the equipment in relation to the dimensions of the cleanroom play a significant role in avoiding any possibility of contamination of sterile products. Additionally, ergonomics enable easier equipment handling by the staff and easier sanitation process.

Comments

Popular posts from this blog

Checklist for Audit in Sterile Area

Checklist for Audit in Sterile Area Checklist to verify the sterile manufacturing area before the audit. 1. Is there any SOP giving details for activity/ movement in the sterile area. 2. Verify the suitability of system for sanitization of hands. 3. Is there the SOP on entry-exit; gowning and de-gowning into the critical area available? 4. Verify the availability of following records:  Air pressure differential  Particulate monitoring  Temperature  Humidity  Microbiological monitoring by settle plate 5. Are these records available and maintained as per SOPs? 6. Check the above mentioned individual records. Are the entries within specifications mentioned in SOP/ MTPs. 7. Is the controlled copy of MTP pertaining to monitoring by settle plate available to plant person? 8. Are the location for settle plates identified and the chart/ layout available with plant? 9. Are the following areas monitored for parameters mentioned in step 4:  Air-lock to the critical ar...

Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals

Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals Validation of sterile manufacturing process by media fill validation test as per PICS guidelines for aseptic validation or aseptic process simulation. 1.0 OBJECTIVE 1.1 To define procedures for validating and maintaining the validation of all aseptic filling processes and qualification of the quality of the product by system/facility/equipment. 2.0 SCOPE 2.1 This procedure applies to all aseptically filled sterile products intended for human use. 3.0 RESPONSIBILITY 3.1 The Validation personnel coordinate the aseptic filling validation program and write the sterile media aseptic filling processes reports. 3.2 Manufacturing personnel the sterile media aseptic filling processes and performs the sterile media fills. 3.3 QA personnel perform the sampling and assist with the IPQA monitoring required for each sterile media fill. 3.4 QC personnel to perform the testing and assist with the monitoring required fo...

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing Know about sterile pharmaceutical production using Blow Fill Seal (BFS) and Form Fill Seal (FFS) technology. Both of these techniques are used to manufacture  sterile pharmaceutical products   as parenteral (LVP & SVP), infusions, ophthalmic and inhalation products. These are automated techniques to prepare sterile products. The basic concept of the  FFS   and BFS is to reduce the  contamination   by forming the container, filling and sealing in a closed sterile chamber of the machine. There is no personnel intervention to reduce the chances of the contamination during the manufacturing of sterile products. It gives more production at very low operational cost with the high assurance of  sterility . Blow fill seal technology is widely used and accepted by the various pharmaceutical regulatory authorities as US-FDA and MHRA. The system is being used for over 30 years a...